Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell

NCT04642911 is registered in ClinicalTrials.gov with Ukraine Association of Biobank as lead sponsor.

NCT NCT04642911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell
Lead sponsor
Ukraine Association of Biobank
Phase
Observational
Overall status
Active, not recruiting
Start date
October 15, 2020
Completion date
October 10, 2030
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, mesenchymal stem cell